Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
In this blog, well explore how these therapies work, why theyre effective, and how you can use them to recover from a night out or a medical procedure
Phase 3 confirmation (TRIUMPH programme) Eli Lillys pivotal phase 3 TRIUMPH programme confirmed and extended the phase 2 signal
US biotech Regeneron Pharmaceuticals (Nasdaq: REGN) today announced a strategic in-licensing agreement with Chinas Hansoh Pharmaceuticals (03692: HK) for exclusive clinical development and commercial rights outside of the Chinese Mainland, Hong Kong and Macau for a dual GLP-1/GIP receptor agonist currently in Phase III testing
Singh M, Jindal D, Kumar R, Pancham P, Haider S, Gupta V, et al
US$ 25.47
US$ 24.64
US$ 28.79
US$ 26.64
US$ 26.91
US$ 22.68
US$ 27.42
US$ 20.93
